Aspira Women's Health (AWH)
(Delayed Data from NSDQ)
$0.81 USD
-0.03 (-3.58%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $0.80 -0.01 (-0.76%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth B Momentum C VGM
Income Statements
Fiscal Year end for Aspira Women's Health Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 9 | 8 | 7 | 5 | 5 |
Cost Of Goods | 4 | 4 | 4 | 3 | 3 |
Gross Profit | 5 | 4 | 3 | 1 | 1 |
Selling & Adminstrative & Depr. & Amort Expenses | 24 | 37 | 36 | 19 | 16 |
Income After Depreciation & Amortization | -19 | -33 | -33 | -18 | -15 |
Non-Operating Income | 2 | 6 | 1 | 0 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -17 | -27 | -32 | -18 | -15 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -17 | -27 | -32 | -18 | -15 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -17 | -27 | -32 | -18 | -15 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -19 | -33 | -32 | -18 | -15 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 0 | 0 | 0 |
Income After Depreciation & Amortization | -19 | -33 | -33 | -18 | -15 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 9.23 | 7.77 | 7.42 | 6.72 | 5.78 |
Diluted EPS Before Non-Recurring Items | -1.81 | -3.45 | -4.20 | -2.70 | -2.70 |
Diluted Net EPS (GAAP) | -1.81 | -0.23 | -4.20 | -2.70 | -2.70 |
Fiscal Year end for Aspira Women's Health Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 2.42 | 2.15 | 2.13 | 2.22 | 2.49 |
Cost Of Goods | 1.00 | 0.94 | 0.92 | 0.91 | 0.94 |
Gross Profit | 1.42 | 1.21 | 1.21 | 1.31 | 1.55 |
SG&A, R&D, and Dept/Amort Expenses | 5.81 | 5.93 | 5.86 | 5.43 | 5.87 |
Income After SG&A, R&D, and Dept/Amort Expenses | -4.39 | -4.72 | -4.65 | -4.12 | -4.32 |
Non-Operating Income | 0.86 | 0.08 | 1.05 | -0.59 | 2.00 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | -3.53 | -4.63 | -3.60 | -4.71 | -2.32 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -3.53 | -4.63 | -3.60 | -4.71 | -2.32 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -3.53 | -4.63 | -3.60 | -4.71 | -2.32 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 12.52 | 11.85 | 10.41 | 9.78 | 8.40 |
Diluted EPS Before Non-Recurring Items | -0.28 | -0.39 | -0.30 | -0.48 | -0.28 |
Diluted Net EPS (GAAP) | -0.28 | -0.39 | -0.32 | -0.48 | -0.28 |